Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

microRNAs; n/a; transcription; ischemia/reperfusion injury; DSS-colitis; kidney inflammation; therapeutics targets; CXCL13; glomerulus; interleukin-6; rhabdomyolysis; IgA nephropathy; CREB Regulated Transcriptional Coactivators (CRTC); slit diaphragm; injury; xanthine oxidase; Salt Inducible Kinase (SIK); acute and chronic kidney disease; therapeutic target; KIT-IgA score; G-protein-coupled bile acid receptor (TGR5); lysophosphatidic acid; glomerular injury; IL-18; mesenchymal stem cells; Taiwan; acute kidney injury; renal ischemia-reperfusion; long non-coding RNA; fibrosis; acute kidney failure; diabetic kidney diseases; chronic kidney disease; lncRNA; LPS-binding protein; endotoxemia-induced oliguric kidney injury; dapagliflozin; cPLA2 and COX-2; NLRP3 inflammasome; CmklR1; haem; chronic kidney injury; omega-3 fatty acid; noninvasive; inflammation; regulated necrosis; GLP-1 receptor agonists; miRNA; AKI; SGLT2 inhibitors; diabetic kidney disease; extracellular vesicles; podocin; type IV collagen; epithelial cells; nephrin; 2-kidney-1-clip; renal fibrosis; papilla; diagnostics; necrosis; non-coding RNAs; podocyte; Thy1.1 nephritis; KIT assay; oxidative stress; conditioned medium; C-reactive protein; pericyte; myofibroblast; Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-?B); endotoxemia; modifier gene; polymorphism; renal stem cells; kidney; polyploidization; Class IIa Histone Deacetylases (HDAC); 2k1c; molecular signaling; proximal tubule; arachidonic acid; empagliflozin; tubular injury; signaling cascade; signal transduction; inflammatory maker; niches; biomarkers; renal progenitors; type V collagen; cyclooxygenase; focal segmental glomerulosclerosis; inflammatory bowel disease (IBD); chronic kidney disease (CKD); allograft rejection; renovascular hypertension; genotype; molecular mechanisms; ROS; prediction; glomerular filtration barrier (GFB); alport syndrome; scattered tubular cells; long non-coding RNAs; renal inflammation; lysophosphatidic acid receptor; cAMP Regulatory Element Binding Protein (CREB); Farnesiferol B; differentiation; mesenchymal stromal cells; modified-MSCs; kidney transplantation; polyunsaturated fatty acids; apoptosis; type I collagen; diabetes mellitus; natural products; lipoxygenase; stem cell; T cell-mediated rejection; exosomes; renal injury; obese kidney fibrosis; kidney injury; cytotoxicity; mesenchymal stem cell; pigment nephropathy; mesodermal stem cell; ischemia-reperfusion; cytochrome P450; renal cell carcinoma; hematuria; B-cell attracting chemokine; microRNA; chemerin; glomerular basement membrane; glomerular damage; renal tubular cells; kidney proximal tubule; exosome; hypertension; diabetic nephropathy